QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.011619v1 67/6/2070    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, J. Articles by Liu, C. Search for Related Content PubMed PubMed Citation Articles by Chen, J. Articles by Liu, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene

Identification and Pharmacological Characterization of Prokineticin 2 as a Selective Ligand for Prokineticin Receptor 1

Johnson & Johnson Pharmaceutical Research and Development, LLC, San Diego, California

Prokineticins 1 and 2 (PK1 and PK2) have been recently identified from humans and other mammals and play multiple functional roles. PK proteins are ligands for two G protein-coupled receptors, PK receptor 1 (PKR1) and PK receptor 2 (PKR2). Here, we report the molecular cloning and pharmacological characterization of an alternatively spliced product of the PK2 gene encoding 21 additional amino acids compared with PK2, designated PK2L (for PK2 long form). PK2L mRNA is broadly expressed, as is PK2. However, PK2L mRNA expression is lower in brain, undetectable in kidney, and much higher in lung and spleen than that of PK2. We expressed PK2L in mammalian cells and characterized the resulting peptide in comparison with PK1 and PK2. Biochemical characterization indicates that secreted PK2L protein is processed into a smaller peptide by proteolytic cleavage. We designate this smaller form of peptide as PK2. Coexpression of furin with PK2L significantly increased the PK2 processing efficiency. Functional studies showed that PK1, PK2, and PK2 stimulate intracellular Ca²⁺ responses in PKR1-expressing cells with similar potencies. However, the PK2 stimulus of Ca²⁺ responses in PKR2-expressing cells is at least 10-fold less potent than that of PK1 or PK2. Differences in receptor selectivity combined with differential tissue expression patterns suggest PK2 and PK2 might have different functions in vivo. PKRs have been reported to couple to G_q and G_i proteins. In this report, we show that PKs not only stimulate Ca²⁺ mobilization but also induce cAMP accumulation in PKR-expressing cells.

Received for publication February 1, 2005.

Accepted for publication March 16, 2005.

Address correspondence to: Dr. Changlu Liu, 3210 Merryfield Row, San Diego, CA 92121. E-mail: cliu9{at}prdus.jnj.com

This article has been cited by other articles:

				E. Giannini, R. Lattanzi, A. Nicotra, A. F. Campese, P. Grazioli, I. Screpanti, G. Balboni, S. Salvadori, P. Sacerdote, and L. Negri The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain PNAS, August 25, 2009; 106(34): 14646 - 14651. [Abstract] [Full Text] [PDF]

				M. Keramidas, C. Faudot, A. Cibiel, J.-J. Feige, and M. Thomas Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells J. Endocrinol., March 1, 2008; 196(3): 473 - 482. [Abstract] [Full Text] [PDF]

				N. Pitteloud, C. Zhang, D. Pignatelli, J.-D. Li, T. Raivio, L. W. Cole, L. Plummer, E. E. Jacobson-Dickman, P. L. Mellon, Q.-Y. Zhou, et al. From the Cover: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism PNAS, October 30, 2007; 104(44): 17447 - 17452. [Abstract] [Full Text] [PDF]

				K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis FASEB J, September 1, 2007; 21(11): 2980 - 2993. [Abstract] [Full Text] [PDF]

				Q.-Y. Zhou The Prokineticins: A NOVEL PAIR OF REGULATORY PEPTIDES Mol. Interv., December 1, 2006; 6(6): 330 - 338. [Abstract] [Full Text] [PDF]

				L. Li and K. A. Borkovich GPR-4 Is a Predicted G-Protein-Coupled Receptor Required for Carbon Source-Dependent Asexual Growth and Development in Neurospora crassa. Eukaryot. Cell, August 1, 2006; 5(8): 1287 - 1300. [Abstract] [Full Text] [PDF]

				S.-i. Matsumoto, C. Yamazaki, K.-h. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. PNAS, March 14, 2006; 103(11): 4140 - 4145. [Abstract] [Full Text] [PDF]